ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes
Asian Pacific Journal of Cancer Prevention
◽
10.31557/apjcp.2021.22.12.4037
◽
2021
◽
Vol 22
(12)
◽
pp. 4037-4042
Author(s):
Saroj Hattakitpanitchakul
◽
Sirorat Kobbuaklee
◽
Kitsada Wudhikarn
◽
Chantana Polprasert
Keyword(s):
Myelodysplastic Syndromes
◽
Low Risk
◽
Prediction Of Response
◽
Erythropoiesis Stimulating Agents
Download Full-text
Related Documents
Cited By
References
Management of anemia in low-risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents
Medical Oncology
◽
10.1007/s12032-018-1135-2
◽
2018
◽
Vol 35
(5)
◽
Cited By ~ 3
Author(s):
Roberto Castelli
◽
Riccardo Schiavon
◽
Valentina Rossi
◽
Giorgio Lambertenghi Deliliers
Keyword(s):
Myelodysplastic Syndromes
◽
Low Risk
◽
Erythropoiesis Stimulating Agents
Download Full-text
MDS-391: Role of Erythropoiesis-Stimulating Agents (ESAs) in Supportive Care of Low-Risk Myelodysplastic Syndromes
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/s2152-2650(20)30983-6
◽
2020
◽
Vol 20
◽
pp. S324-S325
Author(s):
Claudio Cerchione
◽
Fiorella Alfinito
◽
Ilaria Soriente
◽
Alfonso Maria D'Arco
◽
Paolo Danise
◽
...
Keyword(s):
Supportive Care
◽
Myelodysplastic Syndromes
◽
Low Risk
◽
Erythropoiesis Stimulating Agents
Download Full-text
Faculty Opinions recommendation of TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.10045957.10797055
◽
2011
◽
Author(s):
Michael Williams
Keyword(s):
Disease Progression
◽
Myelodysplastic Syndromes
◽
Low Risk
◽
Tp53 Mutations
◽
Predict Disease Progression
Download Full-text
Erythropoiesis-stimulating agents for myelodysplastic syndromes
10.1002/14651858.cd009995
◽
2012
◽
Author(s):
Andrés M Acevedo
◽
Myriam Lucía Rodríguez
◽
Henry A Becerra
◽
Andrés Felipe Cardona
◽
Arturo J Martí-Carvajal
Keyword(s):
Myelodysplastic Syndromes
◽
Erythropoiesis Stimulating Agents
Download Full-text
Increased serum C-reactive protein is an adverse prognostic factor in low-risk myelodysplastic syndromes
International Journal of Hematology
◽
10.1007/s12185-021-03187-7
◽
2021
◽
Author(s):
Yuta Baba
◽
Bungo Saito
◽
Shotaro Shimada
◽
Yohei Sasaki
◽
Shun Fujiwara
◽
...
Keyword(s):
Prognostic Factor
◽
Myelodysplastic Syndromes
◽
Low Risk
◽
C Reactive Protein
◽
Reactive Protein
◽
Adverse Prognostic Factor
Download Full-text
Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents
British Journal of Haematology
◽
10.1111/j.1365-2141.2011.08979.x
◽
2011
◽
Vol 156
(5)
◽
pp. 619-625
◽
Cited By ~ 29
Author(s):
David Sibon
◽
Giovanna Cannas
◽
Fiorenza Baracco
◽
Thomas Prebet
◽
Norbert Vey
◽
...
Keyword(s):
Myelodysplastic Syndromes
◽
Lower Risk
◽
Erythropoiesis Stimulating Agents
Download Full-text
208 MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS: EVALUATION OF ERYTHROPOIETIC ASPECTS AND ANALYSIS OF RESPONSE
Leukemia Research
◽
10.1016/s0145-2126(15)30209-5
◽
2015
◽
Vol 39
◽
pp. S104
Author(s):
C. Cerchione
◽
O. Vitagliano
◽
L. Simeone
◽
A.E. Pareto
◽
I. Soriente
◽
...
Keyword(s):
Myelodysplastic Syndromes
◽
Erythropoiesis Stimulating Agents
Download Full-text
DNA instability in low-risk myelodysplastic syndromes: refractory anemia with or without ring sideroblasts
Human Molecular Genetics
◽
10.1093/hmg/ddn113
◽
2008
◽
Vol 17
(14)
◽
pp. 2144-2149
◽
Cited By ~ 10
Author(s):
B. Novotna
◽
R. Neuwirtova
◽
M. Siskova
◽
Y. Bagryantseva
Keyword(s):
Myelodysplastic Syndromes
◽
Low Risk
◽
Refractory Anemia
◽
Dna Instability
◽
Ring Sideroblasts
Download Full-text
A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Francais des Myelodysplasies
British Journal of Haematology
◽
10.1111/j.1365-2141.2005.05817.x
◽
2005
◽
Vol 131
(5)
◽
pp. 609-618
◽
Cited By ~ 34
Author(s):
Didier Bouscary
◽
Laurence Legros
◽
Micheline Tulliez
◽
Stephanie Dubois
◽
Beatrice Mahe
◽
...
Keyword(s):
Phase Ii
◽
Myelodysplastic Syndromes
◽
Phase Ii Study
◽
Low Risk
◽
Dose Escalating
Download Full-text
Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond?9th European Hematology Association Congress Geneva, Switzerland, 10?13 June 2004
Transfusion Medicine
◽
10.1111/j.1365-3148.2006.00681.x
◽
2007
◽
Vol 17
(3)
◽
pp. 151-160
◽
Cited By ~ 3
Author(s):
P. Fenaux
◽
J. M. Bennett
◽
D. T. Bowen
◽
R. D. Knight
◽
A. F. List
Keyword(s):
Myelodysplastic Syndromes
◽
Low Risk
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close